)

Applied DNA Sciences (APDN) investor relations material
Applied DNA Sciences Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Strategic restructuring completed, focusing exclusively on nucleic-acid production for biopharma and diagnostics, with significant workforce reductions and exit from legacy businesses.
Transitioned to a pure play synthetic DNA and mRNA manufacturing provider, closing MDx Testing Services and winding down DNA Tagging and Security Products to focus on LineaRx.
Two reverse stock splits executed in March (1:50) and June (1:15) 2025 to address Nasdaq compliance and capital structure.
CEO transition occurred in June 2025, with a new CEO appointed and cost-saving measures implemented.
Launched new products and expanded customer base, including a significant follow-on order and new U.S.-based mRNA CDMO customer.
Financial highlights
Total revenues for the quarter ended June 30, 2025, were $304,393, down 36% year-over-year; nine-month revenues were $1,937,506, up 19%.
Net loss for the quarter was $3,984,109, compared to net income of $1,849,501 in the prior year; nine-month net loss was $9,988,942, up from $3,774,563.
Gross profit for the quarter was $5,130 (2% margin), down from $242,601 (51% margin) year-over-year; nine-month gross profit was $1,006,887 (52% margin), up from $772,829 (48%).
Cash and cash equivalents at June 30, 2025, were $4,727,677, including $723,000 from warrant exercises.
Monthly net cash burn from operations was $934,000, down 19% sequentially and 25% year-over-year.
Outlook and guidance
Management expresses substantial doubt about the ability to continue as a going concern without additional capital or improved revenues.
Expects further reduction in cash burn in the quarter ending September 30, 2025, due to ongoing cost optimization.
Projected annual payroll savings from restructuring are expected to be partially offset by $300,000 in one-time charges.
Focus remains on commercializing core DNA/RNA production technologies and expanding into biotherapeutics and diagnostics markets.
Anticipates ISO 13485 certification in Q1 FY2026 to enhance market opportunities and competitive position.
Next Applied DNA Sciences earnings date

Next Applied DNA Sciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage